Rate My Professor Wimal Pathmasiri

Pathmasiri's research interests center on developing and applying metabolomics to uncover metabolic pathway perturbations linked to disease states, therapeutic interventions, and environmental exposures. Key areas include cancer, childhood obesity, early-life antibiotic exposure, environmental toxicology, kidney disease, osteoarthritis, and rare diseases, with a focus on microbial metabolism and human health interactions. He has received prestigious awards such as the Helmsley Fellowship in Proteomics at Cold Spring Harbor Laboratory (2016), RTI President's Award (2012), RTI Outstanding Paper Award (2016), and RTI Highly Cited Author (2015). Among his significant publications are "Associations between the gut microbiome and metabolome in early life" (Nguyen et al., BMC Microbiology, 2021), "Untargeted analysis of first trimester serum to reveal biomarkers of pregnancy complications: a case-control discovery phase study" (Harville et al., Scientific Reports, 2021), "Metabolomics reveals biomarkers of opioid use disorder" (Ghanbari et al., Translational Psychiatry, 2021), "A Metabolomics Approach to Investigate Kukoamine B - A Potent Natural Product With Anti-diabetic Properties" (Li et al., Frontiers in Pharmacology, 2018), and "A systems biology approach utilizing a mouse diversity panel identifies genetic differences influencing isoniazid-induced microvesicular steatosis" (Church et al., Toxicological Sciences, 2014). Pathmasiri's work contributes to biomarker discovery and nutrigenomics, enhancing insights into exposome-health relationships.